See All Slides - tctmd.com

Slides

Presentation

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Presenter: 35236|Harvey White

March 16, 2012

Presentation

Volumen de Intervenciones Neuroquirúrgicas por Hospital en EE.UU.

Presenter: 202444|M Grigoryan

March 16, 2012

Presentation

Neurointerventional Procedural Volume Per Hospital in United States

Presenter: Mikayel Grigoryan

March 15, 2012

Presentation CIT 2012

The Rewards of Setting Up Collaborative Research Initiatives

Presenter: Martin B. Leon

March 15, 2012

Presentation CIT 2012

How to start and set up a Research Program? The Basic Tools

Presenter: Roxana Mehran

March 15, 2012

Presentation

Mini-COREA: Celecoxib, una Espada de Doble Filo para Pacientes con Angina

Presenter: H. J. Kang

March 14, 2012

Presentation

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Presenter: Anthony J. Furlan

March 14, 2012

Presentation

Mini-COREA: Celecoxib, a Double-edged Sword for Patients with Angina

Presenter: H.J. Kang

March 14, 2012

Presentation

CLOSURE I: Cierre o Tratamiento Médico contra el ACV Criptogénico con Foramen Oval Permeable

Presenter: Anthony J. Furlan

March 14, 2012

Presentation

Estrategia basada en Medir la Función Plaquetaria para Reducir las Hemorragias en el Tiempo de Espera en Pacientes Tratados con Clopidogrel que se someten a un CABG

Presenter: E. Mahla

March 13, 2012

Advertisement

Slides

Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI

Volumen de Intervenciones Neuroquirúrgicas por Hospital en EE.UU.

Neurointerventional Procedural Volume Per Hospital in United States

The Rewards of Setting Up Collaborative Research Initiatives

How to start and set up a Research Program? The Basic Tools

Mini-COREA: Celecoxib, una Espada de Doble Filo para Pacientes con Angina

CLOSURE I: Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

Mini-COREA: Celecoxib, a Double-edged Sword for Patients with Angina

CLOSURE I: Cierre o Tratamiento Médico contra el ACV Criptogénico con Foramen Oval Permeable

Estrategia basada en Medir la Función Plaquetaria para Reducir las Hemorragias en el Tiempo de Espera en Pacientes Tratados con Clopidogrel que se someten a un CABG

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content